Equifax, Inc. · NYSE:EFX
Equifax — Barclays Credit Bureau Day 2024
13 slides from Equifax's conference presentation, Sep 4, 2024
Slide 1: The NewEFX… Faster Growth, Higher Margins, Accelerating FCF
The NewEFX… Faster Growth, Higher Margins, Accelerating FCF September 4, 2024
Slide 2: Forward-looking Statements
Forward-looking Statements This presentation contains certain forward-looking information to help you understand Equifax and its business environment. All statements that address operating performance and events or developments that we expect or anticipate will occur in the future, including stateme
Slide 3: EFX executing against EFX2026 strategic priorities in tougher mortgage market
EFX executing against EFX2026 strategic priorities in tougher mortgage market NewEFX… 8-12% revenue growth powered by EFXCloud competitive advantages Strong top line growth… 1H C$ Non-mortgage revenue up 11%… 2H24 EFX C$ Guidance up STRATEGIC PRIORITIES 11%, 2H24 Non-Mortgage C$ up 10%… high end of
Slide 4: EFX Long Term Framework
EFX Long Term Framework Long Term Financial Framework New EFX Organic revenue growth 7-10% LTFF Revenue Growth M&A contribution 1-2% EWS USIS INTL Total growth 8-12% 13-15% 6-8% 7-9% EBITDA% margin improvement +50 bps Cash EPS growth 12-16% Dividend yield ~1% Annual shareholder return 13-18% Faster
Slide 5: Cloud… ~90% of Revenue in the Cloud by Year End
All USIS Consumer Customers Migrated to EFX Cloud… ~90% of Revenue in the Cloud by Year End PROPRIETARY | 5
Slide 6: ~$13B EWS Growth Opportunity
~$13B EWS Growth Opportunity TAM ($B) Market Share % EWS Revenue Opportunity EFX Other Players / Manual / Lack of Adoption $15B Talent Sol $5B 10% 90% ~$2B Empl. Svcs 16% 84% Government $5B 15% 85% ~$13B 20% 80% ~$11B Verification Employer $2B Housing1 $1.5B 40% 60% $2.3B Cons. Fin.2 $1.5B 15% 85% To
Slide 7: Strong 30% EWS Government revenue growth in 2Q with big room for growth in $5B TAM
Strong 30% EWS Government revenue growth in 2Q with big room for growth in $5B TAM Gov’t Benefits Enrollment¹ EWS Government Revenue TANF Housing 1M Key Growth Areas 5M SSA 12M ✓ CMS contract extension $5B ($1.2B) SNAP TAM 23M ✓ SNAP expansion CAGR 50%+ ✓ State and local penetration CMS / ACA 38M ✓ R
Slide 8: Strong 12% TWN active record growth in 2Q… Added Workday as a strategic partner
Strong 12% TWN active record growth in 2Q… Added Workday as a strategic partner in August Total US Records ~225M Unique Individuals ✓ TWN active records up 12% to 180M in 2Q… ~50M - 70M total records up 10% to 695M 1099 / Pension Individuals ✓ 3.4 million companies contribute records to TWN ✓ Added
Slide 9: Strong 12.5% NPI Vitality Index in 2Q… Over 30 NPIs in Second Quarter
Strong 12.5% NPI Vitality Index in 2Q… Over 30 NPIs in Second Quarter New Product Vitality Index1 % New Models Built Using AI / ML Key Areas 80% ✓ Strong 12.5% VI… broad 10% LT based across all regions LT Goal ✓ FY24 VI 10%+ Goal ✓ EWS VI 17% ✓ USIS VI accelerating… 8% in 2Q24 vs 7% in 1Q24 ✓ Intern
Slide 10: 2Q USIS Mortgage credit inquiries in line with April framework
2Q USIS Mortgage credit inquiries in line with April framework Mortgage Market Credit Inquiries EFX 2024 Guidance Assumption YoY Growth 2015-2019 Average Level of Inquiries Number of Inquiries 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Full year 15% 12% (-6%) (-8%) 6.5% 47% (-7.5%) (-37%) (-3
Slide 11: $1B+ Revenue Upside in 2025+ from Mortgage Market Return to Normal
$1B+ Revenue Upside in 2025+ from Mortgage Market Return to Normal EFX Mortgage Credit Inquiries Down ~(-50%) EFX Mortgage Revenue ~$2.2B ~$1.1B 2025+ Opportunity ~$1.1B ~50% 2015 - 2019 Inquiry Level ~$1.1B mortgage revenue upside as market returns to 2015-19 levels PROPRIETARY | 11
Slide 12: The NewEFX
The NewEFX C$ Non-Mortgage +20% ✓ 8-12% LT growth… 1-2 pts from Bolt-on M&A ✓ Mortgage Tailwind… $1.1B upside to normal Mortgage market ✓ 50 BPS margin expansion per year +10% 10%+ ✓ Cloud competitive advantage ✓ 10%+ Vitality Index from EFX.AI, NPIs ✓ Accelerating FCF ✓ Return cash to shareholders
Slide 13: Confidential & Proprietary
Copyright © 2022 Equifax Inc. All Rights Reserved. Equifax is a registered trademark of Equifax Inc. CONFIDENTIAL & PROPRIETARY | 13